Efficacy and Mechanism of Transcutaneous Auricular Vagus Nerve Stimulation in Patients With Poststroke Dysphagia: Protocol for a Randomized, Sham-Controlled Clinical Trial.
5 affiliations
- 1The Fifth College of Clinical Medicine, Guangzhou University of Traditional Chinese Medicine, Guangzhou, China.
- 2Guangdong Provincial Engineering Technology Research Institute of Traditional Chinese Medicine, Guangzhou, Guangdong, China.
- 3Guangdong Provincial Key Laboratory of Research and Development in Traditional Chinese Medicine, Guangzhou, Guangdong, China.
- 4Department of Acupuncture and Rehabilitation, Guangdong Provincial Second Hospital of Traditional Chinese Medicine, 60 Hengfu Road, Yuexiu District, Guangzhou, Guangdong, China, 86 18319673139.
- 5Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences, Beijing, Beijing, China.
Abstract
Background
Dysphagia is a common complication following stroke. While current management strategies for poststroke dysphagia (PSD) range from nutritional support to neurostimulation techniques, an optimal treatment regimen remains elusive. As a promising noninvasive neuromodulation approach, transcutaneous auricular vagus nerve stimulation (taVNS) requires further validation in rigorously designed trials to establish robust evidence of its efficacy and mechanisms of action.Objective
This study aims to validate the efficacy of taVNS in treating PSD and to elucidate its underlying mechanisms, thereby supporting the development of a novel, noninvasive therapeutic strategy for improving swallowing function in stroke survivors.Methods
This study will use a prospective, randomized, double-blind, controlled trial design. A total of 40 patients with PSD will be enrolled and randomly allocated to either a taVNS group or a sham taVNS group. Both groups will receive conventional swallowing rehabilitation therapy as the baseline intervention. The taVNS group will receive bilateral electrical stimulation at the cymba conchae and cavum conchae of the auricle. These sites correspond to the "Heart" and "Kidney" auricular acupoints, selected in accordance with traditional Chinese medicine theory. In contrast, the sham taVNS group will receive stimulation at regions of the auricle not innervated by the vagus nerve. The primary outcome measure will be the Penetration-Aspiration Scale score. Secondary outcomes will include the Yale Pharyngeal Residue Severity Rating Scale, hyoid bone displacement and hyoid-thyroid approximation distance assessed via B-mode ultrasonography, and motor-evoked potentials of the suprahyoid muscles elicited by transcranial magnetic stimulation. All outcome measures will be evaluated at baseline and after the 2-week intervention period.Results
This paper describes the protocol for a study evaluating the efficacy and mechanisms of taVNS in patients with PSD. The study was funded in January 2025. Participant recruitment began in March 2025 and is projected to conclude by October 2026. Data collection began in March 2025 and is projected to be completed by October 2026. Primary study results are expected to be submitted for publication in winter 2026.Conclusions
This study aims to validate the efficacy of taVNS in treating PSD and to elucidate its underlying mechanisms, thereby supporting the development of a novel, noninvasive therapeutic strategy for improving swallowing function in stroke survivors.
Related
- Efficacy and neural mechanisms of transcutaneous auricular vagus nerve stimulation for chronic insomnia: a study protocol for a randomized controlled trial
- Efficacy of diadynamic currents versus transcutaneous electrical nerve stimulation for transcutaneous tibial nerve stimulation in subjects with overactive bladder syndrome: A double-blind randomized controlled trial
- Transcutaneous low-level vagus nerve stimulation for the prevention of postoperative atrial fibrillation after cardiac valve surgery with cardiopulmonary bypass: protocol for a randomized controlled trial.
- Efficacy of Transcutaneous Auricular Trigeminal Nerve Stimulation in Migraine: A Randomized, Participant- and Assessor-Blinded, Sham-Controlled Trial
- Effects of synchronous versus sequential scalp acupuncture and transcutaneous auricular vagus nerve stimulation on post-stroke cognitive impairment based on multimodal assessments: a single-center randomized controlled trial protocol
BibTeX
@article{gao2026efficacy,
title = {{Efficacy and Mechanism of Transcutaneous Auricular Vagus Nerve Stimulation in Patients With Poststroke Dysphagia: Protocol for a Randomized, Sham-Controlled Clinical Trial.}},
author = {Luming Gao and Jin Li and Miao Xie and Canyi Xu and Changying Zhang and Weichuan Kuang and Xi Wen and Xiaoyin Wang and Yue Liu and Yu Wang and Tong Liu},
journal = {JMIR research protocols},
year = {2026},
month = oct,
doi = {10.2196/95182},
url = {https://europepmc.org/article/MED/42949639},
note = {CC BY},
}
RIS
TY - JOUR
TI - Efficacy and Mechanism of Transcutaneous Auricular Vagus Nerve Stimulation in Patients With Poststroke Dysphagia: Protocol for a Randomized, Sham-Controlled Clinical Trial.
AU - Luming Gao
AU - Jin Li
AU - Miao Xie
AU - Canyi Xu
AU - Changying Zhang
AU - Weichuan Kuang
AU - Xi Wen
AU - Xiaoyin Wang
AU - Yue Liu
AU - Yu Wang
AU - Tong Liu
PY - 2026
DA - 2026/10/01
JO - JMIR research protocols
DO - 10.2196/95182
UR - https://europepmc.org/article/MED/42949639
AB - Background Dysphagia is a common complication following stroke. While current management strategies for poststroke dysphagia (PSD) range from nutritional support to neurostimulation techniques, an optimal treatment regimen remains elusive. As a promising noninvasive neuromodulation approach, transcutaneous auricular vagus nerve stimulation (taVNS) requires further validation in rigorously designed trials to establish robust evidence of its efficacy and mechanisms of action.Objective This study aims to validate the efficacy of taVNS in treating PSD and to elucidate its underlying mechanisms, thereby supporting the development of a novel, noninvasive therapeutic strategy for improving swallowing function in stroke survivors.Methods This study will use a prospective, randomized, double-blind, controlled trial design. A total of 40 patients with PSD will be enrolled and randomly allocated to either a taVNS group or a sham taVNS group. Both groups will receive conventional swallowing rehabilitation therapy as the baseline intervention. The taVNS group will receive bilateral electrical stimulation at the cymba conchae and cavum conchae of the auricle. These sites correspond to the "Heart" and "Kidney" auricular acupoints, selected in accordance with traditional Chinese medicine theory. In contrast, the sham taVNS group will receive stimulation at regions of the auricle not innervated by the vagus nerve. The primary outcome measure will be the Penetration-Aspiration Scale score. Secondary outcomes will include the Yale Pharyngeal Residue Severity Rating Scale, hyoid bone displacement and hyoid-thyroid approximation distance assessed via B-mode ultrasonography, and motor-evoked potentials of the suprahyoid muscles elicited by transcranial magnetic stimulation. All outcome measures will be evaluated at baseline and after the 2-week intervention period.Results This paper describes the protocol for a study evaluating the efficacy and mechanisms of taVNS in patients with PSD. The study was funded in January 2025. Participant recruitment began in March 2025 and is projected to conclude by October 2026. Data collection began in March 2025 and is projected to be completed by October 2026. Primary study results are expected to be submitted for publication in winter 2026.Conclusions This study aims to validate the efficacy of taVNS in treating PSD and to elucidate its underlying mechanisms, thereby supporting the development of a novel, noninvasive therapeutic strategy for improving swallowing function in stroke survivors.
SN - 1929-0748
ER -